More than 50 meetings with prospective partners from Japan, Belgium, South Korea, Taiwan, Germany, Finland, France were held during BioJapan 2017 exhibition and the partnering event for the global biotechnology industry, on October 11-13.
“Japan is one of the most important export destinations for Lithuanian life sciences industry. Japanese appreciate our products and achievements in biotechnology, biomedicine, pharmacy, laser technologies. The aim of our visit was to pitch Lithuanian companies producing life sciences research products and services, present the country’s potential in the sector,” said Ms Daina Kleponė, General Manager of Enterprise Lithuania, a non-profit governmental agency which aims to drive and foster entrepreneurship and Lithuanian producers’ export and is the main organizer of Life Sciences Baltics.
The representatives of Enterprise Lithuania discussed strengthening cooperation with top organizations of life sciences in Japan. During the meetings with representatives of Japan regenerative medicine association FIRM, Japan Bioindustry Association, Japan Agency for Medical Research and Development the views on opportunities for Lithuanian companies and universities were exchanged. A large Japanese delegation is expected to visit the Life Sciences Baltics, the largest event for life sciences in the Baltic region, as all the partners were invited to take part in the Forum.
“Japan is one of the most important export destinations for Lithuanian life sciences industry,” – Ms Kleponė said.
“The visit in Japan demonstrated the enormous potential for the cooperation between Lithuanian and Japanese scientists. The life sciences growth in Lithuania is based on well-developed research and development as well as educational systems with approximately 10,000 students studying health and life sciences and more than 22,000 researchers involved in developing innovative solutions in the fields of drugs, medical devices, genetic engineering, etc. Lithuania should aim to continuously foster this cooperation with joint internships and scientific research projects, which in turn would serve Lithuanian scientists as the opportunity to observe the newest technologies and innovations,” – Ms Kleponė said.
During a week in Japan Ms Kleponė with the Lithuanian delegation under the leadership of Aurelijus Veryga, the Lithuanian Minister of Health, visited various Japanese science and health care institutions and held meetings with top level executives. Just like Japan, Lithuania is interested in international cooperation in the most relevant life sciences fields: age-related diseases, regenerative medicine, laser technologies in medical devices, technological solutions for healthcare. These topics will be covered in Life Sciences Baltics 2018 where more than 1,300 participants from around 40 countries are expected.
Enterprise Lithuania aims to strengthen Lithuanian life sciences ecosystem by cooperating with leading countries on the global scene. In Japan Lithuania is well known for the laser industry and laser products which are used in medicine and science. Lithuania is the only Baltic country to showcase and present the sector at the BioJapan 2017.